News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - Patent News
HemaFLO Therapeutics Announces Issuance Of Key Patent For NephroFlow 2/8/2016
VLP Therapeutics Announces Issuance Of U.S. Composition Of Matter Patent For I-A Virus Like Particle Platform Technology 2/8/2016
Palatin Tech (PTN) Strengthens Intellectual Property Surrounding Use Of Bremelanotide For Female Sexual Dysfunction 2/8/2016
BMC Medical Co., Ltd Wins Patent Infringement Litigation Against ResMed (RMD) 2/8/2016
Therapeutics Solutions Announces The Licensing Of Exosome Technology To MolecuVax, Inc. 2/8/2016
Zealand Pharma  (ZEAL.CO) Clarifies Its Role In U.S. Patent Litigation Relating To Lixisenatide And Confirms Its Confidence In A Strong Patent Status For The Product 2/5/2016
Almac Discovery Secures Patent Protection For Novel Allosteric Akt inhibitor (ALM301) 2/4/2016
CorMatrix Cardiovascular Secures Forty-one (41) U.S. Patents In 2015 Including Additional Prosthetic Heart Valve Patents 2/4/2016
Regen BioPharma Files Patent Application Covering Innate Immune Activating NR2F6 Silenced CAR-T Cell For Solid Tumors 2/3/2016
Amarantus BioSciences Receives Dual Notices Of Allowance From European Patent Office For Engineered Skin Substitute (ESS) 2/3/2016
Trianni Announces Issuance Of Patent In Australia 2/3/2016
Cantargia Patent Granted In Australia 2/3/2016
Kymab Succeeds In Revoking Regeneron (REGN)’s UK VelocImmune Patents 2/2/2016
Reflow Awarded New U.S. Patent For Innovative Wingman Crossing Catheter Technology 2/2/2016
Dipexium Pharmaceuticals (DPRX) Announces Issuance Of Locilex Patents In Australia And New Zealand 2/1/2016
Amarantus BioSciences Announces Issuance Of Chinese Patent Covering Use Of MANF For The Treatment Of Parkinson's Disease 1/29/2016
Prima Biomed (PRR.AX) Release: U.S. Patent Grants For IMP731 Antibody 1/28/2016
Telephus Medical Announces Issuance of Canada Patent for Anti-MRSA Antibodies 1/27/2016
BiondVax Pharmaceuticals's Universal Flu Vaccine Receives Additional US Patent 1/27/2016
Axsome Announces Issuance Of U.S. Patent Covering AXS-02 For The Treatment Of Bone Marrow Lesions Of The Knee 1/27/2016
Thetis Awarded Key Patent On HEALER Technology 1/27/2016
Kaleo Announces The Award Of Its 100th Patent 1/26/2016
Premier Biomedical Files Provisional Patent Application On Second Drug To Treat Fibromyalgia, Neuropathic Pain, MS Symptoms, And Alcohol And Chemical Addiction 1/26/2016
AEterna Zentaris (AEZS) Files International Patent Application For Novel Method Of Manufacturing Zoptrex 1/26/2016
Rosetta Genomics Ltd. (ROSG) Granted U.S. Patent Allowance For Use Of Gene Expression Signature For Classification Of Kidney Tumors 1/25/2016
OncBioMune Receives Notice Of Allowance For Patent Covering New Targeted Cancer Treatments 1/22/2016
Kadimastem Receives Patent Allowance In The United States For Its Technology In The Field Of Diabetes Treatment 1/21/2016
Sample6 Awarded New Patent For Phage Engineering Technology 1/21/2016
Dramatic Turn In Story Of Invalidated '813 Patent For Treating Binge Eating Disorder As Owner Lucerne Biosciences Provides Patent Board Profile Of Itself And Its High 40-75% Misrepresentation Rate 1/21/2016
Agienic Release: Three Key Patents Issued To Antimicrobial Company 1/21/2016
U.S. Patent & Trademark Office Issues Notice Of Allowance For Can-Fite BioPharma (CFBI)'s Sexual Dysfunction Drug CF602 1/19/2016
Summit Therapeutics Granted Key European Patent For Novel Antibiotic Ridinilazole For Treatment Of C. Difficile Infection 1/19/2016
Swedish Orphan Biovitrum's Orfadin Oral Suspension Granted European Patent 1/19/2016
EastGate Biotech Receives Notice Of Publication From The US Patent And Trademark Office For Two Patents For The Company's Proprietary Intraoral Lorazepam Spray 1/19/2016
Telephus Medical Announces Issuance Of Japanese Patent For Anti-MRSA Antibodies 1/18/2016
Amgen (AMGN) Cringes as Officials Reject Petition Against AbbVie (ABBV) Patents 1/18/2016
Lucerne Biosciences Completes Sourcing Investigation Into Shire (SHPG)'s IPR That Led To The Invalidation Of The '813 Patent 1/15/2016
Alitair Pharmaceuticals Announces Issuance Of Patent Covering Its Prescription Drug Overdose Reduction Technology, ODR 1/15/2016
Mach 7 Technologies Awarded U.S. Patent For Medical Image Capture With A Mobile Device 1/13/2016
Lucerne Biosciences Completes Sourcing Investigation Into Shire (SHPG)'s IPR That Led To The Invalidation Of The '813 Patent; Begins Accelerated Multi-Party Public Expansion Phase Of Its Counter-Intelligence Technology 1/12/2016
Halo-Bio RNAi Therapeutics Issued U.S. Patent For New Class Of RNAi Trigger 1/12/2016
Entac Medical Announces U.S. Patent Issuance For Platform Technology To Predict Gastrointestinal Impairment In Surgical Patients 1/12/2016
Key Patents Granted For Probiodrug AG’s pGlu-Abeta Targeting Monoclonal Antibody Program For The Treatment Of Alzheimer’s Disease 1/11/2016
SpinalCyte, LLC Receives New Chinese Patent For Spinal Disc Tissue Engineering 1/8/2016
Gen9 Awarded Four U.S. Patents For Innovation In Synthetic Biology 1/8/2016
BioMarker Strategies Announces Issuance Of Key Patents In The United States, Europe, Australia And Hong Kong 1/7/2016
Enzo Biochem (ENZ) Reaches $9 Million Patent Infringement Settlement With Agilent Technologies Inc. (A) 1/6/2016
Valencell Files Patent Infringement Suit Against Apple (AAPL) And Fitbit, Inc. 1/5/2016
Orthocell’s ‘Cell Factory’ Granted Patent in U.S. 1/5/2016
Helius Medical Technologies Announces Allowances Of 10 New Patents 1/5/2016
VolitionRX Granted Its Third U.S. Patent 1/4/2016
Cantargia Patent Granted By The European Patent Office 1/4/2016
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering RAVICTI (Glycerol Phenylbutyrate) Oral Liquid 1/4/2016
AlloSource Granted Two Patents For Innovations In Cartilage Repair 12/29/2015
Sunshine Biopharma, Inc. Acquires All Remaining Worldwide Patents For Its Adva-27a Anticancer Compound 12/28/2015
VistaGen Therapeutics, Inc. Secures Exclusive Worldwide Commercial Rights To Three Proprietary Stem Cell Technologies From University Health Network 12/23/2015
Celgene (CELG) Settles REVLIMID Patent Litigation 12/23/2015
AlloSource Granted Patent For Innovative Dermal Allograft For Wound Care 12/22/2015
Wolf Greenfield And Client BTG Reach Favorable Outcome In IPR For Crofab Rattlesnake Antivenom Patent 12/22/2015
BiondVax Pharmaceuticals Approval For A Patent For Its Universal Flu Vaccine In Israel 12/21/2015
Creative Medical Health Granted U.S. Patent For Heart Failure Stem Cell Therapy 12/21/2015
AlloSource Receives Patent For AlloStem Cellular Bone Allograft 12/18/2015
Can-Fite BioPharma (CFBI)'s CF101 Granted Patent In Japan For Intraocular Pressure A Key Cause Of Glaucoma 12/17/2015
OphthaliX Inc. Announces CF101 Is Granted Patent In Japan For Intraocular Pressure A Key Cause Of Glaucoma 12/17/2015
Symic Receives New U.S. Patent For Osteoarthritis Program 12/16/2015
TrovaGene, Inc. Announces Patent Issuance, Broadening Its Precision Cancer Monitoring IP Portfolio 12/16/2015
GeneriCo Files For Inter Partes Review Of United States Patent 8,865,688 12/16/2015
Intec Pharma Ltd. Further Expands Intellectual Property With A New Patent For The Accordion Pill Zaleplon In Europe 12/16/2015
Eiger Biopharma Announces Notice Of Allowance For U.S. Patent Covering Bestatin (Ubenimex) For The Treatment Of Pulmonary Arterial Hypertension 12/15/2015
Amarantus Receives Notice Of Allowance For U.S. Patent Application Covering Method Of Treating Parkinson's Disease Levodopa-Induced Dyskinesia (PD-LID) 12/15/2015
Regeneus (RGS.AX) (ASX:RGS) Patent Granted For Cancer Vaccine Technology 12/15/2015
bioAffinity Technologies Announces Patent Award In China 12/15/2015
ImmunID Strengthens Its Intellectual Property Position With The Issuance Of A Key Technology Patent In China 12/14/2015
U.S. Patents Issued To Akaal Pharma On S1P1 Receptor Modulators Useful For The Treatment Of Autoimmune And Inflammatory Diseases 12/11/2015
Genisphere Awarded Patent For Cellular Delivery Of SiRNA And Other Therapeutics Using 3DNA Nanocarrier 12/10/2015
Euclises Pharmaceuticals Receives Notice Of Patent Allowance From European Patent Office For New Class Of Compounds For Treatment Of Cancer, Pain And Inflammation 12/10/2015
Orthocell Key Scaffold Patent Granted In Canada 12/9/2015
Google (GOOG) Files Patent to Draw Your Blood Without Needles 12/8/2015
Vapir Enterprises Is Granted Its Sixth U.S. Patent 12/7/2015
Neothetics Announces Issuance By USPTO Of Fourth Patent Directed To LIPO-202 Lead Clinical Asset 12/7/2015
Strongbridge Biopharma Announces Issuance Of U.S. Patent For Investigational COR-003 (Levoketoconazole) In Treatment Of Endogenous Cushing's Syndrome 12/7/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Chinese Patent for Key TB4 Peptide Fragment 12/4/2015
Arch Therapeutics Receives Notice Of Allowance For New Patent In The United States 12/4/2015
Sequenom (SQNM) Comments On U.S. Court Of Appeals For The Federal Circuit Decision On '540 Patent 12/3/2015
Trevena, Inc. (TRVN) Granted Key Composition Of Matter And Use Patent For TRV027 In Europe 12/3/2015
GenVec Inc. (GNVC) Receives Notice Of Allowance For Patent Application Providing Broad Protection Of Its Gorilla Adenovectors 12/2/2015
OncoRx Pharma Announces Issuance Of Third Patent For Controlling Resistant Tumors 12/2/2015
Nevro Announces The U.S. Patent And Trademark Office's Denial Of Boston Scientific (BSX) Petitions For Inter Partes Review Of U.S. Patent No. 8,359,102 12/1/2015
Newly Granted U.S. Composition Of Matter Patent Extends Exclusive Protection For VBL Therapeutics (VBLX)' Lead Drug Candidate VB-111 Until October 2033 12/1/2015
Acasti Pharma Granted Composition & Use Patent In Japan, Taiwan And Mexico 12/1/2015
Myriad Genetics (MYGN) Release: United States Patent And Trademark Office Grants Patent For Vectra DA 12/1/2015
Prolifiq Software Announces Issuance Of US Patent For Tracking Digital Content Objects 12/1/2015
Patent Granted For Additional Polymer Technology Originated At Particle Sciences 12/1/2015
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering PENNSAID2% 12/1/2015
iBio, Inc. (IBIO) Continues Global Expansion Of Intellectual Property 12/1/2015
Cleveland Biolabs Inc. (CBLI) Announces Expanded U.S. Patent Protection For Entolimod 12/1/2015
Biocept, Inc. (BIOC) Gains Patent Protection In Hong Kong And Japan 11/30/2015
PTS Diagnostics Expands Patent Portfolio With Technology Enabling Testing On Mobile Devices 11/30/2015
Sunesis (SNSS) Announces European Patent Covering Vosaroxin Combination Use In AML And Other Hematologic Malignancies 11/30/2015
Enyo Pharma Strengthens Its Arsenal Of Hepatitis B Potential Therapies 11/30/2015
La Jolla Pharma (LJPC) Announces Notice Of Allowance For U.S. Patent Covering LJPC-501 11/30/2015
iX Biopharma Secures Indonesia Patent For Waferix Technology 11/30/2015
Avacen Medical Release: New Concept For Chronic Pain Treatment Patent Issued 11/25/2015
Orthocell Key Patents Granted For Celgro And Ortho-ATI 11/25/2015
Synthetic Biologics, Inc. (SYN) Announces Issuance Of First Key U.S. Patent Directly Covering SYN-010, The Company's Novel Candidate For Irritable Bowel Syndrome With Constipation (IBS-C) 11/24/2015
Zero Gravity Solutions Receives Notification Of Patent Approval For Its Commercial Product, BAM-FX From The United States Patent And Trademark Office 11/24/2015
ERS Genomics Licenses Genome-Editing Patents To Regeneron (REGN) 11/24/2015
Therapeutic Solutions International Files Patent On Anticancer Nanotechnology Based Immunotherapy 11/24/2015
Valencell Expands Intellectual Property Portfolio With Critical Patents Enabling Highly Accurate Biometric Fitness And Health Assessments 11/23/2015
The Medicines Patent Pool Signs Licence With Bristol-Myers Squibb (BMY) To Increase Access To Hepatitis C Medicine Daclatasvir 11/23/2015
MiMedx Awarded 12 New U.S. Patents YTD 2015 With Four Awarded For Its Amniotic Membrane Allografts And Eight Awarded For Its CollaFix Technology 11/20/2015
Mylan (MYL) Confirms First-to-File Patent Challenge Relating To DELZICOL 11/20/2015
Arthrex Serves Second Patent Infringement Lawsuit Against Smith & Nephew plc (SNN) 11/20/2015
Cumberland Pharmaceuticals (CPIX) Announces Favorable Acetadote Patent Ruling 11/20/2015
Celator Pharmaceuticals, Inc. Receives Allowance Of Expanded U.S. Claims On CombiPlex Technology 11/19/2015
BioRestorative Granted Key Metabolic Patent 11/19/2015
Ortek Therapeutics Files Patent Applications For New Microbiome Altering Compositions And Methods For Reducing Body Odor Causing Bacteria And Staphylococcus Aureus Proliferation 11/19/2015
PolyPid Ltd. Announces Issuance Of New U.S. Patent For Doxycycline Sustained Release Compositions 11/19/2015
Otoharmonics Receives Patent Approval For Levo Tinnitus System 11/18/2015
CSIRO Maintains Key Patent For shRNA Gene Silencing Technology After European Opposition 11/18/2015
Glytec LLC Receives Approval From The USPTO On Another Patent 11/18/2015
First Singapore Patient Receives Orthocell’s Cartilage Cell Therapy Ortho-ACI 11/18/2015
Cardax Pharmaceuticals Inc. Awarded U.S. Inflammation Patent 11/18/2015
VolitionRX Granted Its Second U.S. Patent 11/17/2015
CEL-SCI (CVM) Is Granted A New European Patent On Its Phase III Investigational Cancer Immunotherapy Multikine 11/17/2015
Patent Approval For BiondVax Pharmaceuticals: BiondVax Receives Approval For Patent In Korea For Its Universal Flu Vaccine 11/17/2015
POXEL Announces Patent Access Agreement With Enyo Pharma 11/17/2015
Zecotek Photonics Inc. Granted Two U.S. Patents For 3D Display System 11/16/2015
Premier Biomedical Receives Notice Of Allowance On Broad Base Patent Involving Innovative Extracorporeal Treatment Therapy – Premier Believes This May Lead To Cancer Cure 11/16/2015
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering VIMOVO (Naproxen/Esomeprazole) Delayed Release Tablets 11/16/2015
U.S. Patent Awarded To Singulex, Inc. For Expanded Use Of Biomarkers Troponin I And T To Detect Cardiac Health Status With Single-Molecule Methods 11/12/2015
Egalet Announces Issuance Of U.S. Patent Covering Guardian Technology And Its Abuse-Deterrent Product Candidates 11/12/2015
Novogen Limited (NVGN) Patent Covering Cantrixil And Trilexium Accepted In Australia 11/12/2015
Merck & Co. (MRK) Statement Regarding CUBICIN (Daptomycin For Injection) Patent Litigation 11/12/2015
Clearside Biomedical Announces Fifth Patent Issued In The U.S. Related To Proprietary Microneedle Drug Delivery Methods And Devices 11/12/2015
Regulus (RGLS) Announces Grant Of Patents Covering Lead microRNA Therapeutics 11/12/2015
Biocept, Inc. (BIOC) Expands Patent Protection In Europe 11/11/2015
Regeneus (RGS.AX) (ASX:RGS) Patent Granted For Allogeneic Stem Cell Technology Platform 11/11/2015
MediciNova, Inc. Receives Notice Of Allowance For New Patent Covering MN-221 (Bedoradrine) For The Treatment Of Irritable Bowel Syndrome In Japan 11/11/2015
Hi-Tech Pharmaceuticals Files Lawsuit Against Ironmag Labs And Robert Dimaggio Over Racketeer Influenced And Corrupt Organizations (RICO) And Patent Infringement 11/10/2015
Rock Creek Pharmaceuticals Announces European Patent 11/10/2015
Cellectar Biosciences  (NVLT) Converts Patent Application For Phospholipid-Ether Analogs As Cancer Targeting Drug Vehicles 11/10/2015
Thrasos Strengthens Composition Of Matter Coverage On THR-184 With Japanese Patent Decision 11/10/2015
Syros Pharmaceuticals Announces Issuance Of U.S. Patents Related To Its Gene Control Drug Discovery And Development Platform 11/10/2015
KATOR Granted US Patent For Innovative Suture Anchor Technology 11/9/2015
DS Biopharma Obtains A Granted Patent Covering The Use Of DS102 To Treat Fatty Liver Disorders 11/9/2015
REPLICor Inc. Announces Grant Of US Patents On HBV / HDV Treatment Methods Combining HBsAg Reduction And Immunotherapy 11/9/2015
PTS Diagnostics ' Patent Enforcement Against Jant Pharmacal Gains Momentum 11/6/2015
Singulex, Inc. Receives European Patent Expanding Use Of Biomarkers Troponin I And T To Detect Cardiac Health Status With High-Sensitivity Methods 11/5/2015
Regen BioPharma Files Patent Application On Personalized Checkpoint Inhibitor Cancer Immunotherapy 11/4/2015
BioCad Release: Russian Biotechnological Company Won The Case Against Big Pharma On The Patent Dispute Notable For The Pharmaceutical Industry 11/3/2015
BioRestorative Announces Patent Granted For Its Licensed Curved Needle Device 11/3/2015
Glaukos, Transcend Medical Settle Eye Stent Patent Spat 10/30/2015
BioPharm Executive: From Bad to Worse: Biotech's Next Political Headache? 10/29/2015
In Vitro ADMET Laboratories Announces US Patent On Pooled Cryopreserved Human Hepatocytes For Drug Development Research 10/29/2015
Amarantus BioSciences, Inc. Announces Issuance Of Australian Patent No. 61/057,713 Covering Eltoprazine Treatment Of Parkinson’s Disease And Alzheimer’s Disease 10/29/2015
Fate Therapeutics (FATE) Strengthens Intellectual Property Position With New U.S. Patent Covering Induced Pluripotent Cell Compositions 10/28/2015
Enzymotec Granted A New U.S. Patent For Vayacog In Pre-Dementia 10/28/2015
WaferGen Biosystems Receives Notice Of Patent Grant And Allowance For Methods And Systems Utilizing Multi-Well Chips 10/28/2015
Mesoblast (MSB.AX) Release: Key United States Patent Granted For The Treatment Of Heart Diseases, Stroke And Other Vascular Conditions 10/28/2015
Cancer Genetics (CGIX) Receives Third Patent For Proprietary Genomic FHACT Test, Further Advancing The Detection And Treatment Of Cervical And Other HPV-Associated Cancers 10/28/2015
Regenexx Announces Issue of United States Patent On Proprietary Orthopedic Stem Cell Procedure 10/28/2015
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering VIMOVO (Naproxen/Esomeprazole) Delayed Release Tablets 10/28/2015
Arena (ARNA) Issued Additional Patent Covering BELVIQ (lorcaserin HCl) By United States Patent And Trademark Office 10/27/2015
Twi Biotechnology Receives Notice Of Patent Allowance In Korea For Its Lead Drug Candidate AC-201 For The Indication Of Type II Diabetes 10/27/2015
Endonovo Files Patent Application on Cell Therapy Created Using Its Proprietary Cell-Enhancing Cytotronics Platform 10/27/2015
iBio, Inc. (IBIO) European Protein Expression Patent Emerges From Opposition Period 10/27/2015
Skystar Bio-Pharmaceutical (CGPN) Receives Approval For T-Factor Animal Supplement Patent From PRC's Patent Office 10/27/2015
OrPro Therapeutics Receives US Patent Covering Novel Enzymatic Treatment for Cystic Fibrosis 10/27/2015
Rexahn Pharmaceuticals, Inc. (RNN) Receives U.S. Patent for RX-3117 Anti-Cancer Program 10/27/2015
Orexo AB (ORXOF) Settles Abstral US Patent Litigation With Actavis (ACT) 10/27/2015
Medtronic (MDT) Challenges a Pair of Masimo (MASI) Patents 10/26/2015
Manhattan Scientifics, Inc. Announces Chinese Patent Issued For The Early Cancer Detection Technology Platform 10/26/2015
U.S. Patent And Trademark Office Issues Notices Of Allowance In Two Pending NP-500 Patent Applications Licensed Exclusively By Jaguar Animal Health For Veterinary Use 10/26/2015
Matinas BioPharma Receives Notice Of Allowance Of U.S. Patent For Encochleated siRNA 10/26/2015
First US Patent Covering Allogeneic Chimeric Antigen Receptor T Cells ("CAR-T") Modified To Reduce Immunogenicity Is Awarded To Celyad 10/23/2015
Align Technology, Inc. (ALGN) Files Patent Infringement And False Advertising Lawsuit Against SmileCareClub, Sharper Image, And Brookstone 10/23/2015
Horizon Pharma (HZNP) Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering PENNSAID (diclofenac sodium topical solution) 2% 10/22/2015
Intec Pharma Ltd. Expands Intellectual Property With A New Patent For The Accordion Pill In Europe 10/22/2015
SteadyMed (STDY) Files Inter Partes Review To Invalidate United Therapeutics (UTHR) Patent 10/21/2015
Therabron Therapeutics Receives Notice of Allowance for New EU Patent Supporting its Recombinant CC10 Technology Platform 10/20/2015
Fluoresentric, Inc.USPTO Grants New And Expanded Patent Claims 10/20/2015
XBiotech Strengthens Intellectual Property Portfolio For Its True Human Antibody Technology 10/19/2015
NuGene International, Inc. Files Provisional Patent Applications to Enhance Wound Treatment by Combining Micro-Current Electro-Active Dressings with Human Adipose-Derived Stem Cell Media 10/19/2015
Supernus Pharmaceuticals (SUPN) Announces Settlement With Par On Trokendi XR Patent Litigation 10/15/2015
EyeGate Pharma Receives USPTO Notice Of Allowance For Next Generation Of Proprietary Iontophoretic Delivery System 10/15/2015
LS CancerDiag Receives Patent For Revolutionary Predictive Cancer Diagnostic Method Diagmmr 10/15/2015
Threshold Pharmaceuticals, Inc. (THLD) Receives Two U.S. Patents For Tarloxotinib Bromide 10/14/2015
Angle Release: New Patent Grant 10/14/2015
SpinalCyte, LLC Receives New Australian Patent For Spinal Disc Tissue Engineering 10/14/2015
Glytec LLC Receives Patent On Innovative Diabetes Management Mobile App 10/14/2015
Capstone Therapeutics (CAPS) Announces Allowance Of U.S. Patent For Treatment Of Diabetes With Apo E Mimetic Peptides 10/14/2015
Catalyst Pharmaceuticals (CPRX) Announces Notice Of Allowance Of A U.S. Patent Application For The Method Of Treating Tourette's Disorder With GABA-Aminotransferase Inactivators 10/13/2015
KemPharm Enhances U.S. And Global Intellectual Property Estate 10/13/2015
Enzo Biochem (ENZ) Reaches $10 Million Patent Infringement Settlement With Affymetrix (Santa Clara, California) (AFFX) 10/13/2015
Miacom Diagnostics Announces Issuance Of A Patent For Innovative In Vitro Diagnostic Probes 10/13/2015
Arcadia Biosciences (RKDA) Receives U.S. Patent For Resistant Starch Wheat Technology 10/12/2015
Ignyta (RXDX) Announces Issuance Of Patent Covering Composition Of Matter Of RXDX-107 10/7/2015
Neothetics Announces Issuance By USPTO Of Additional Patent Directed To LIPO-202 Lead Clinical Asset 10/6/2015
InCarda Issued Broad Patents In U.S., Australia And Canada 10/6/2015